YY

Yamini Yadunandan Jaluka

Active Director Designated Partner DIN 08920770
DIN 08920770 First appointment Oct 2020 Primary industry Research & Development
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2020
Shareholding value β€’β€’β€’β€’ Premium profile

About Yamini Yadunandan Jaluka

Data last updated:

Yamini Yadunandan Jaluka is a Designated Partner at Pathovision Biomedicals Llp (since 2020). The company operates in Research & Development.

DIN 08920770
Primary Designation Designated Partner
Industry Research & Development
First Appointment 15 Oct 2020
Oldest Company Age 6 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner15 Oct 20202020Active

Board colleagues of Yamini Yadunandan Jaluka

NameDINCompanyDesignation
Yadunandan Jaluka08869943Pathovision Biomedicals LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Pathovision Biomedicals Llp
Premium access

Shareholding and investment profile for Yamini Yadunandan Jaluka

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Yamini Yadunandan Jaluka

Yamini Yadunandan Jaluka currently holds 1 directorship: Pathovision Biomedicals Llp (Designated Partner, since 15 Oct 2020).

Yamini Yadunandan Jaluka was first appointed on 15 Oct 2020 as Designated Partner at Pathovision Biomedicals Llp.

The current boards of Yamini Yadunandan Jaluka's companies include Yadunandan Jaluka (Pathovision Biomedicals Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available